-+ 0.00%
-+ 0.00%
-+ 0.00%
Chong Kun Dang Corrects Quarterly Report to Add Omitted Subsidiary Investment Disclosures
Share
Listen to the news
Chong Kun Dang Corrects Quarterly Report to Add Omitted Subsidiary Investment Disclosures
  • Chong Kun Dang corrected its third-quarter 2026 report on Nov. 16, adding omitted disclosures on subsidiary investments.
  • Subsidiary investments totaled KRW 24.54 million in carrying value at September-end, versus KRW 9.15 million at year-end 2025.
  • Equity-method losses reached KRW 10.22 million, compared with gains of KRW 433,515,000 a year earlier.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chong Kun Dang Pharmaceutical Corporation published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261116002243), on November 16, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending